Analytical Data
-
基因名
PLCL2
- Application
-
别名
PLCE2; Phospholipase C,Epsilon 2; Inactive phospholipase C-like protein 2
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UPR0
-
表达区间
Phe829~Glu1127
-
分子量
37kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PLCL2 (phospholipase C-like 2) is a member of the phospholipase C (PLC) family, which is known for its role in cellular signaling pathways that regulate various physiological processes, including cell growth, differentiation, and apoptosis. Unlike traditional PLCs that hydrolyze phosphatidylinositol bisphosphate (PIP2) to generate inositol trisphosphate (IP3) and diacylglycerol (DAG), PLCL2 possesses a unique mechanism and substrate specificity. Research indicates that PLCL2 is involved in immune response regulation and has implications in diseases, such as cancers and autoimmune disorders. Moreover, PLCL2 expression is regulated by various stimuli, suggesting its potential role in adaptive cellular responses. The recombinant expression of PLCL2 protein allows for detailed biochemical studies to elucidate its functional characteristics and interactions with other signaling molecules. Understanding PLCL2’s structure-function relationship and its involvement in signaling pathways can provide insights into therapeutic targets and biomarker development for diseases associated with dysregulated signaling. Therefore, the study of recombinant PLCL2 is crucial for uncovering its biological significance and potential clinical applications.
